Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 197

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 197
---
 obligations and commitments. Contingencies From time to time, the Company may become subject to claims and litigation arising in the ordinary course of business. The Company is not a party to any material legal proceedings, nor is it aware of any material pending or threatened litigation. 5. 2023 Public Offering On February 13, 2023, the Company closed a public offering of 6,017shares of its common stock, 699pre-funded warrants to purchase shares of common stock with an exercise price of $ 0.048which did not have an expiration date (the “Class C Pre-Funded Warrants”) and 6,450,000warrants to purchase up to 13,438shares of common stock with an exercise price of $ 2,572.80which expire on February 14, 2028(the “Class C Common Stock Warrants”) at a combined offering price of $ 2,318.40per share of common stock and two Class C Common Stock Warrants, or $ 2,318.352per Class C Pre-Funded Warrant and two Class C Common Stock Warrants (the “February 2023 Public Offering”). Net cash proceeds to the Company from the offering were $ 14.0million and issuance costs were $ 1.5million. Roth Capital Partners, LLC (“Roth”) was engaged by the Company to act as its exclusive placement agent for the February 2023 Public Offering. The Company paid Roth a cash fee equal to 8.0% of the gross proceeds received by the Company in the public offering, totaling $ 1.2million of issuance costs. The shares of common stock underlying the Class C Pre-Funded Warrants and the shares of common stock underlying the Class C Common Stock Warrants were registered with the SEC on Form S-1 (File No. 333-268576) and was declared effective by the SEC on February 9, 2023. Between February 14, 2023 and April 6, 2023, the Company received notices of cash exercise for the Class C Pre-Funded Warrants issued in connection with the February 2023 Public Offering for 699shares of common stock at a total purchase price of $ 33.64. As of December 31, 2024, there were noClass C Pre-Funded Warrants outstanding. Using a Monte-Carlo simulation model, the Class C Common Stock Warrants were valued in the aggregate at $ 14.0million and included